pfizer glp-1 news dips on new data for obesity drug acquired in $10B deal Pfizer just made a quiet

& Mietlicki-Baase, E

Meurot C, Martin C, Sudre L, Breton J, Bougault C, Rattenbach R, Bismuth K, Jacques C, Berenbaum F (2022) Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

The news: Hims & Hers reported a $92 million Q1 net loss, driven by a $33 million write-down related to its compounded GLP-1 business

These clinicians assess patient information submitted through the online evaluation and independently determine whether a GLP-1 prescription is appropriate

For clinicians and patients navigating medication-induced weight gain and treatment-resistant symptoms, this conversation lays out current evidence, open questions, and how to discuss risks and benefits in real-world care